博客

MSC Therapy for Pulmonary Fibrosis: 2026 Preclinical and Clinical Evidence Review

A medical review of MSC-based and MSC-derived EV therapies for idiopathic pulmonary fibrosis, covering meta-analysis data, immune-cloaked cell engineering, nebulized exosome delivery, gut-lung axis mechanisms, and active…

Sep 23, 2026

MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal

The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce …

Sep 7, 2026

为什么你的干细胞在40岁后会减缓活动（以及科学界正在如何应对这一问题）

Research shows MSC activity drops 40% by age 50. Learn what changes inside aging cells and three emerging therapies showing real results in 2026 clinical trials.

Sep 4, 2026

MSC临床试验：ISCT都柏林会议揭示了半月板修复、线粒体移植和细胞来源方面的信息

A medical review of MSC clinical trials 2026: key evidence from ISCT Dublin, a Japanese phase III synovial-MSC meniscal repair trial, bone marrow vs cord tissue OA data, and mitochondrial EV mechanisms.

Aug 28, 2026

呼吸更顺畅：干细胞疗法如何改变泰国慢性阻塞性肺病的治疗

Our Bangkok clinic explores how MSC therapy is helping COPD patients breathe easier — reducing inflammation, reactivating lung stem cells, and improving quality of life.

Aug 28, 2026

脊髓损伤干细胞疗法：2026 年的研究将告诉我们脊髓损伤后 MSC 疗法的哪些信息

Japan approved the world’s first MSC therapy for spinal cord injury in 2018. Here’s what six years of real-world data and 2026 mechanism research tell us about where MSC therapy for SCI actually stands.

Aug 27, 2026

在曼谷进行干细胞治疗后的恢复周期间会发生什么？

Planning a trip to Bangkok for stem cell therapy involves more than just scheduling your procedure date. International patients need to know: What does the post-treatment recovery week actually look like? Whether receivi…

Aug 24, 2026

Stem Cell Therapy for Erectile Dysfunction: A Patient’s Guide to the 2026 Evidence

Diabetic ED, post-prostatectomy ED, PDE5 non-responders — here’s what 2026 trials and clinical experience show for stem cell therapy: who is a candidate, what the procedure looks like, what it costs, and what to expect.

Aug 22, 2026

Do Stem Cells Require Blood Type Matching? Biological Facts Explained

One of the most frequent clinical questions patients ask before undergoing regenerative treatment is whether receiving donor stem cells requires blood typing (ABO and Rh factor matching) or cross-matching, similar to a b…

Aug 21, 2026

MSC Therapy for Multiple Sclerosis: What 17 Trials and Tell Us

MSCs are the most promising cell therapy in progressive MS, and 2026 added the mechanism papers and one well-controlled trial that finally make the case. Here’s what 17 trials, SMART-MS, and the new miRNA work mean for r…

Aug 20, 2026

MSC-Derived Exosomes for Myocardial Infarction: Delivery Systems, Mechanisms, and the Bench-to-Bedside Pipeline

Eight 2026 studies detail how MSC exosomes inhibit ferroptosis, deliver sustained paracrine signaling via hydrogels, and improve LVEF in rat MI models. Here is what translational researchers need to know before the first…

Aug 20, 2026

Harnessing MSC-Derived Exosomes for Advanced Rheumatoid Arthritis Immunotherapy

Discover the groundbreaking potential of MSC-derived exosomes in revolutionizing Rheumatoid Arthritis immunotherapy. Learn about novel nanoplatforms and their mechanism of action.

Aug 19, 2026

Page 2 of 15 — 177 posts